Get started
ALVOTECH SDBALVOTECH SDBALVOTECH SDB

ALVOTECH SDB

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals

ALVO_SDB chart


Full chart

Key stats


Market capitalization
‪30.91 B‬ SEK
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
34.0
Basic EPS (TTM)
3.5 SEK
Net income (FY)
‪−2.58 B‬ SEK
Revenue (FY)
‪5.44 B‬ SEK
Shares float
‪108.97 M‬
Beta (1Y)
—

About Alvotech


Sector
Health Technology
Industry
Biotechnology
CEO
Vilhelm Róbert Wessman
Website
alvotech.com
Headquarters
Luxembourg
Founded
2021
ISIN
SE0025011463
FIGI
BBG01TYGX737
Alvotech is a biotechnology company, which engages in the development and manufacture of biosimilar medicines. The firm is focusing on the development of its product candidates. It operates through the following geographical segments: Europe, North America, Asia, and Other. The company was founded by Róbert Vilhelm Wessman in 2013 and is headquartered in Luxembourg.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

ALVO_SDB news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Check out other big names from the same industry as ALVO_SDB.